Saltar al contenido
Merck
  • Mass Spectrometry-Based Proteomic Characterization of Cutaneous Melanoma Ectosomes Reveals the Presence of Cancer-Related Molecules.

Mass Spectrometry-Based Proteomic Characterization of Cutaneous Melanoma Ectosomes Reveals the Presence of Cancer-Related Molecules.

International journal of molecular sciences (2020-04-26)
Magdalena Surman, Sylwia Kędracka-Krok, Dorota Hoja-Łukowicz, Urszula Jankowska, Anna Drożdż, Ewa Ł Stępień, Małgorzata Przybyło
RESUMEN

Cutaneous melanoma (CM) is an aggressive type of skin cancer for which effective biomarkers are still needed. Recently, the protein content of extracellular vesicles (ectosomes and exosomes) became increasingly investigated in terms of its functional role in CM and as a source of novel biomarkers; however, the data concerning the proteome of CM-derived ectosomes is very limited. We used the shotgun nanoLC-MS/MS approach to the profile protein content of ectosomes from primary (WM115, WM793) and metastatic (WM266-4, WM1205Lu) CM cell lines. Additionally, the effect exerted by CM ectosomes on recipient cells was assessed in terms of cell proliferation (Alamar Blue assay) and migratory properties (wound healing assay). All cell lines secreted heterogeneous populations of ectosomes enriched in the common set of proteins. A total of 1507 unique proteins were identified, with many of them involved in cancer cell proliferation, migration, escape from apoptosis, epithelial-mesenchymal transition and angiogenesis. Isolated ectosomes increased proliferation and motility of recipient cells, likely due to the ectosomal transfer of different cancer-promoting molecules. Taken together, these results confirm the significant role of ectosomes in several biological processes leading to CM development and progression, and might be used as a starting point for further studies exploring their diagnostic and prognostic potential.

MATERIALES
Referencia del producto
Marca
Descripción del producto

SpeedBeads magnetic carboxylate modified particles, Cytiva 65152105050250, 0.70-1.10 μm avg. part. size, suspension (5% Solids)
SpeedBeads magnetic carboxylate modified particles, Cytiva 45152105050250, 1 μm avg. part. size, suspension (5% Solids)
Sigma-Aldrich
Nitrilotriacetic acid disodium salt, Sigma Grade, ≥99%
Sigma-Aldrich
Anti-CD63 Antibody, clone RFAC4, clone RFAC4, Chemicon®, from mouse